BioHarvest Sciences Inc.
BioHarvest Sciences Inc. is a biotechnology company that operates through two segments: Products and CDMO Services. The company has developed a botanical synthesis platform technology to grow plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, and…
1D
+8.8%
1W
+11.4%
1M
+11.4%
6M
-57.5%
YTD
-64.4%
1Y
-83.9%
2Y
–
5Y
–
10Y
–
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~14% stronger price swings than usual
PRICE TARGET LOW
US$5.00
CONSENSUS
US$5.00
MEDIAN
US$5.00
PRICE TARGET HIGH
US$5.00
0
STRONG BUY
3
BUY
0
HOLD
0
SELL
0
STRONG SELL
3
TOTAL · Buy
As of: 12/08/2026
P/E
-3.43
P/B
2.12
EV/EBITDA
-4.58
RETURN ON EQUITY
-18.8%
NET MARGIN
-42.0%
DEBT/EQUITY
0.89
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
83.9%
FLOAT SHARES
14,534,890
AVG. DAILY VOLUME (30D)
25,655
BioHarvest Sciences Inc. is a company in the Industrials sector, Agricultural - Commodities/Milling industry, headquartered in Canada.
The CEO is Zaki Rakib, the company employs around 89 people.
The IPO was on 08/01/2021; the stock trades on NASDAQ under the ticker BHST.
3 analysts rate the stock, the consensus is Buy (as of 12/08/2026).
The average price target is US$5.00, ranging from US$5.00 to US$5.00, with a median of US$5.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly 14% stronger than usual.
No, BioHarvest Sciences currently does not pay a dividend.
Comparable stocks include Canadian Pacific Kansas City, Canadian National Railway Company, Waste Connections, MDA Space, Ballard Power Systems, Electrovaya, Caterpillar and GE Aerospace.
Clicking "Analyze stock" lets five strategies assess BioHarvest Sciences against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.